Primary Hypotension
Conditions
Interventions
Control group:Placebo
Treatment group:Yangxuetongmai Formula
Sponsors
The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
16 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Aged 16 to 75 years, gender is not limited; (2) Meets the diagnostic standard of primary hypotension; (3) Volunteer to participate in the clinical trial, understand and sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with severe heart dysfunction, atrial fibrillation, aortic stenosis, arteritis and other diseases that may lead to reduced blood pressure; (2) Patients who are using antihypertensive drugs, diuretics, sedatives and other medications that may cause blood pressure fluctuations; (3) Patients who had taken TCM preparations within 2 weeks before the study, including TCM decoction, granule, Chinese patent medicine, etc.; (4) Patients with severe mental disorders, malignant tumors, severe blood diseases, acute phase of infectious diseases; (5) Patients with abnormal liver and kidney function (alanine aminotransferase, aspartate aminotransferase or serum creatinine > 2 times the upper limit of normal); (6) Women with positive pregnancy test, planned pregnancy or lactation; (7) Patients who have participated in clinical studies of other drugs within the last 1 month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Fatigue Severity Scale (FSS) score;Scoring of Four Diagnostic Information of Traditional Chinese Medicine;SF-36 Quality of Life score; | — |
Countries
China
Contacts
Public ContactMao Jingyuan
The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Outcome results
None listed